Study:
Long-term Oxygen Treatment Trial
Rationale:
n/a
Purpose:
Chronic obstructive pulmonary disease (COPD) is a serious respiratory disease in which the
airways in the lungs are partially blocked, resulting in symptoms of chest tightness,
coughing, and difficulty breathing. Currently, there are many available treatments for
managing COPD symptoms and improving quality of life, including medications, lifestyle
changes, oxygen therapy, and pulmonary rehabilitation. For people with severe COPD that is
characterized by very low blood oxygen levels at rest, long term oxygen therapy can help to
prolong life and promote feelings of well-being. However, the effectiveness of supplemental
oxygen therapy for people with COPD that is characterized by only moderately low blood
oxygen levels at rest or normal blood oxygen at rest and desaturation on exercise is not
known. This study will evaluate the effectiveness of supplemental oxygen therapy in treating
people with COPD who have moderately low blood oxygen levels at rest or who have normal
blood oxygen levels at rest, but have low or very low blood oxygen levels during exercise.
Study Status: Recruiting
Recruiting:
Jean Barton 954-659-6213 bartonn2@ccf.org
Yvonne Meli 216-445-4215 meliy@ccf.org
| Condition |
Intervention |
Phase |
|
Chronic Obstructive Pulmonary Disease |
Behavioral: Supplemental oxygen therapy |
Phase 3 |
Verified by
National Heart, Lung, and Blood Institute (NHLBI)
May, 2013
Sponsored by: National Heart, Lung, and Blood Institute (NHLBI)
Information provided by: National Heart, Lung, and Blood Institute (NHLBI)
ClinicalTrials.gov identifier: NCT00692198
Study Type: Interventional
Study Design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Weston Florida Cleveland Clinic
Weston, Florida 33331
United States
Cleveland Clinic Foundation
Cleveland, Ohio 44195
United States
William C. Bailey, MD., Study Chair